Testing effectiveness (Phase 2)Not Yet RecruitingNCT06258018What this trial is testingNiraparib and Temozolomide in Patients GlioblastomaWho this might be right forGlioma, Malignant Armando Santoro, MD 86
Not applicableLooking for participantsNCT07111195What this trial is testingFeasibility of ONCOhabitats for Surgical and Treatment Planning in IDH-Wildtype Glioblastoma (SINUE)Who this might be right forGlioblastoma IDH (Isocitrate Dehydrogenase) Wildtype Juan M Garcia-Gomez 140
Testing effectiveness (Phase 2)Looking for participantsNCT07185880What this trial is testingThe Safety and Tolerability of MT-125 in GBM PatientsWho this might be right forGlioblastoma (GBM) Myosin Therapeutics Inc. 36
Testing effectiveness (Phase 2)Looking for participantsNCT05765812What this trial is testingDebio 0123 in Combination With Temozolomide in Adult Participants With Recurrent or Progressive Glioblastoma and of Debio 0123 in Combination With Temozolomide and Radiotherapy in Adult Participants With Newly Diagnosed GlioblastomaWho this might be right forGlioblastoma IDH (Isocitrate Dehydrogenase) WildtypeAstrocytoma, Grade III Debiopharm International SA 116
Early research (Phase 1)Looking for participantsNCT05879367What this trial is testingEvaluation of Eflornithine Plus Temozolomide in Patients With Newly Diagnosed Glioblastoma or AstrocytomaWho this might be right forGlioblastoma, IDH-wildtypeGlioblastomaGlioblastoma Multiforme+4 more Orbus Therapeutics, Inc. 66
Not applicableNot Yet RecruitingNCT07788430What this trial is testingImpact of Pesticide Exposure on Survival and Tumor Aggressiveness in Patients With Glioblastoma: A Prospective Clinical StudyWho this might be right forGlioblastoma IDH (Isocitrate Dehydrogenase) Wildtype Institut Claudius Regaud 120
Large-scale testing (Phase 3)Looking for participantsNCT03970447What this trial is testingA Trial to Evaluate Multiple Regimens in Newly Diagnosed and Recurrent GlioblastomaWho this might be right forGlioblastoma Global Coalition for Adaptive Research 2,250
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07620548What this trial is testingLaser Interstitial Thermal Therapy (LiTT) With Cemiplimab or Other Chemotherapy in Recurrent GlioblastomasWho this might be right forGlioblastomaGlioblastoma, IDH-wildtypeGlioblastoma IDH (Isocitrate Dehydrogenase) Wildtype Washington University School of Medicine 99
Testing effectiveness (Phase 2)Looking for participantsNCT07416188What this trial is testingNovel Indenoisoquinolone CMYC/TOPOISOMERASE 1 Inhibitor (LMP744) in Recurrent GlioblastomaWho this might be right forRecurrent GlioblastomaGlioblastoma IDH (Isocitrate Dehydrogenase) WildtypeRelapsed Cancer+12 more National Institute of Neurological Disorders and Stroke (NINDS) 40
Not applicableStudy completedNCT05375318What this trial is testingBIOhabitats: Biological Validation of Vascular Habitats Within Astrocytoma Grade 4 at Molecular, Cellular, and Histopathological LevelsWho this might be right forAstrocytoma, Grade IVGlioblastomaGlioblastoma Multiforme+5 more Juan M Garcia-Gomez 50
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07604285What this trial is testingSafety and Tolerability of MT-125 With Chemoradiation in Patients With Newly Diagnosed MGMT Methylated GlioblastomaWho this might be right forGlioblastoma Myosin Therapeutics Inc. 36
Not applicableLooking for participantsNCT07668869What this trial is testingTTFields Plus FET-PET-Guided Stereotactic Radiosurgery Versus TTFields Alone for Recurrent Glioblastoma (Tarrget 2.0)Who this might be right forGlioblastomaGlioblastoma IDH (Isocitrate Dehydrogenase) WildtypeGlioblastoma Multiforme, Adult Prof. Franciszek Lukaszczyk Memorial Oncology Center 92
Testing effectiveness (Phase 2)Looking for participantsNCT05864534What this trial is testingPhase 2a Immune Modulation With Ultrasound for Newly Diagnosed GlioblastomaWho this might be right forNewly Diagnosed GlioblastomaGlioblastoma, Isocitric Dehydrogenase (IDH)-WildtypeGliosarcoma+1 more Northwestern University 25
Testing effectiveness (Phase 2)Ended earlyNCT05267106What this trial is testingStudy to Evaluate the Efficacy and Safety of Pemigatinib in Participants With Previously Treated Glioblastoma or Other Primary Central Nervous System Tumors Harboring Activating FGFR1-3 AlterationsWho this might be right forGlioblastomaAdult-type Diffuse Gliomas Incyte Corporation 83
Not applicableLooking for participantsNCT06430424What this trial is testingStudy of Metabolic, Transcriptomic and Proteomic Characteristics in Relapsed GlioblastomaWho this might be right forRelapsed CancerGlioblastoma IDH (Isocitrate Dehydrogenase) Wildtype University Hospital, Bordeaux 40
Testing effectiveness (Phase 2)Active Not RecruitingNCT04677049What this trial is testingStudy of Niacin in GlioblastomaWho this might be right forGlioblastoma IDH (Isocitrate Dehydrogenase) Wildtype AHS Cancer Control Alberta 59
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07386002What this trial is testingThe GLIOMAX Study: MT027 Allogeneic CAR-T for Recurrent GliomaWho this might be right forGlioblastoma IDH (Isocitrate Dehydrogenase) Wildtype T-MAXIMUM Pharmaceutical Inc 40
Very early researchLooking for participantsNCT06552260What this trial is testingA Surgical Window of Opportunity Clinical Trial of Troriluzole in Recurrent IDH Wild-Type GlioblastomaWho this might be right forGlioblastomaRecurrent GlioblastomaBrain Tumor Ugonma Chukwueke 27
Early research (Phase 1)Ended earlyNCT04782609What this trial is testingStudy of Icapamespib (PU-AD) in Patients With Recurrent Malignant GliomaWho this might be right forRecurrent Glioblastoma Multiforme (GBM)Grade 3 Isocitrate Dehydrogenase (IDH) Wildtype AstrocytomaGrade 3 or 4 Astrocytoma+1 more Samus Therapeutics, Inc. 7
Very early researchEnrolling By InvitationNCT07520214What this trial is testingClinical Study on the Safety and Immunogenicity of Specific Cancer Vaccines in Preventing Recurrence of GlioblastomaWho this might be right forGlioblastoma IDH (Isocitrate Dehydrogenase) WildtypeGlioblastom WHO Grade 4 Beijing Neurosurgical Institute 9